Posts by Naomi Serling-Boyd, MD
-
Case Series: Tocilizumab and Tofacitinib for Resolved Hepatitis B Infection
No episodes of hepatitis B virus (HBV) reactivation occurred with tocilizumab or tofacitinib treatment over three to four years of follow-up in a small case series of patients with resolved HBV from a U.S. health care system.
-
Risk of Respiratory Failure Tripled in COVID-19 Patients with Existing Rheumatic Disease
Massachusetts General Hospital clinicians find that patients with rheumatic disease who develop COVID-19 need close monitoring.
Rheumatology, Allergy and Immunology
The Division of Rheumatology, Allergy and Immunology at Massachusetts General Hospital provides leading-edge treatment and transformative care to patients with rheumatic disease and autoimmune conditions.